Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 4

Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report

Pages
296–299
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KALYON, H., ÖZTÜRK, E., TUZLALI, S., YANAR, O., FERHANOĞLU, B. (2019). Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report. Turkish Journal of Hematology, Cilt: 36 - Sayı: 4, 296–299. https://ajindex.com/articles/412368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-2390
  2. Food and Drug Administration. Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Silver Spring, FDA, 2018. Available at https://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ ucm481899.htm. 3. de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbe E, Casparie MK, van Leeuwen FE. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300:2030-2035
  3. Bizjak M, Selmi C, Praprotnik S, Bruck O, Perricone C, Ehrenfeld M, Shoenfeld Y. Silicone implants and lymphoma: the role of inflammation. J Autoimmun 2015;65:64-73
  4. Sieber DA, Adams WP Jr. What’s your micromort? A patient-oriented analysis of breast implant-associated anaplastic large cell lymphoma (BIAALCL). Aesthet Surg J 2017;37:887-891
  5. Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete surgical excision is essential for the management of patients with breast implantassociated anaplastic large-cell lymphoma. J Clin Oncol 2016;34:160-168
  6. Mehta-Shah N, Clemens MW, Horwitz SM. How I treat breast implantassociated anaplastic large cell lymphoma. Blood 2018;132:1889-1898
  7. Bautista-Quach MA, Nademanee A, Weisenburger DD, Chen W, Kim YS. Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules. Clin Breast Cancer 2013;13:492-495
  8. Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MW. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2017;139:1042-1050
  9. Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, Connell T, Lofts J, Locke M, Hopper I, Cooter R, Vickery K, Joshi PA, Prince HM, Deva AK. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 2017;140:645-654. 11. de Boer M, van Leeu